These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 15858126)

  • 21. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions.
    Boucher J; Anku-Bertholet C; Temmar R; Pelmus M
    Hum Pathol; 2009 Jun; 40(6):904-5; author reply 905-6. PubMed ID: 19442790
    [No Abstract]   [Full Text] [Related]  

  • 22. Decreased D2-40 and increased p16INK4A immunoreactivities correlate with higher grade of cervical intraepithelial neoplasia.
    Han H; Yang Y; Lu Z; He Q; Lin Z
    Diagn Pathol; 2011 Jul; 6():59. PubMed ID: 21729305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix.
    Murphy N; Ring M; Heffron CC; Martin CM; McGuinness E; Sheils O; O'Leary JJ
    Mod Pathol; 2005 Jun; 18(6):844-9. PubMed ID: 15696126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
    Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
    Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma.
    Singh M; Mockler D; Akalin A; Burke S; Shroyer A; Shroyer KR
    Cancer Cytopathol; 2012 Feb; 120(1):26-34. PubMed ID: 22162342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
    Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
    Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia.
    Samarawardana P; Dehn DL; Singh M; Franquemont D; Thompson C; Gaido L; Torkko KC; Homer P; Burke S; Titmus MA; Nayi V; Shroyer KR
    Cancer Cytopathol; 2010 Jun; 118(3):146-56. PubMed ID: 20544710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer.
    Butler D; Collins C; Mabruk M; Leader MB; Kay EW
    Gynecol Oncol; 2002 Aug; 86(2):144-9. PubMed ID: 12144820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16 INK4A is a strong biomarker for cervical intraepithelial neoplasia and invasive cervical carcinoma: a reappraisal.
    Haidopoulos D; Partsinevelos GA; Vlachos GD; Rodolakis A; Markaki S; Voulgaris Z; Diakomanolis E; Antsaklis A
    Reprod Sci; 2009 Jul; 16(7):685-93. PubMed ID: 19372590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus detection and p16INK4a expression in cervical lesions: a comparative study.
    Genovés J; Alameda F; Mancebo G; Solé JM; Bellosillo B; Lloveras B; Agramunt S; Baró MT; Muset M; Casado B; Serrano L; Miralpeix E; Carreras R
    Hum Pathol; 2014 Apr; 45(4):826-33. PubMed ID: 24656093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.
    Lin ZH; Shen XH; Jin Z; Kim Y; Lee E; Kim H; Kim I
    Pathol Int; 2005 Aug; 55(8):491-6. PubMed ID: 15998377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
    Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
    Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.
    Tsoumpou I; Arbyn M; Kyrgiou M; Wentzensen N; Koliopoulos G; Martin-Hirsch P; Malamou-Mitsi V; Paraskevaidis E
    Cancer Treat Rev; 2009 May; 35(3):210-20. PubMed ID: 19261387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
    Focchi GR; Silva ID; Nogueira-de-Souza NC; Dobo C; Oshima CT; Stavale JN
    J Low Genit Tract Dis; 2007 Apr; 11(2):98-104. PubMed ID: 17415114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
    Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
    Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining.
    Negri G; Moretto G; Menia E; Vittadello F; Kasal A; Mian C; Egarter-Vigl E
    J Clin Pathol; 2006 Aug; 59(8):827-30. PubMed ID: 16467166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.
    Hoshikawa S; Sano T; Yoshida T; Ito H; Oyama T; Fukuda T
    Pathol Res Pract; 2010 Dec; 206(12):816-20. PubMed ID: 20965668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
    Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
    Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.
    Negri G; Bellisano G; Zannoni GF; Rivasi F; Kasal A; Vittadello F; Antoniazzi S; Faa G; Ambu R; Egarter-Vigl E
    Am J Surg Pathol; 2008 Nov; 32(11):1715-20. PubMed ID: 18769337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.